Advanced glycosylation end products induce nitric oxide synthase expression in C6 glioma cells: Involvement of a p38 MAP kinase-dependent mechanism

Life Sciences

Volumn 69, Issue 21, 2001, Pages 2503-2515

  Lin, Chien Huang ^a   Lin, Yuan Fong ^a   Chang, Meng Chu ^a   Wu, Chih Hsiung ^b   Ho, Yuan Soon ^a   Lee, Horng Mo ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AGEs; C6 glioma cells; iNOS; p38 MAPK

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADVANCED GLYCATION END PRODUCT; CYCLOHEXIMIDE; DACTINOMYCIN; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SYNAPTOPHYSIN; TYRPHOSTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA CELL; GLYCOSYLATION; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SIGNAL TRANSDUCTION;

ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITORS; GLIOMA; GLYCOSYLATION END PRODUCTS, ADVANCED; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR CELLS, CULTURED;

EID: 0035850822     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01330-3     Document Type: Article

References (27)

1. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
2. Glycosylation products as toxic mediators of diabetic complications
3. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease
4. Advanced glycosylation endproducts in aging and Alzheimer's disease
5. Advanced glycation end products (AGEs) induced oxidant stress in the gingiva: A potential mechanism underlying accelerated periodontal disease associated with diabetes
6. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition and possible effect through iNOS or eNOS
7. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy
8. Synthesis and secretion of tumor necrosis factor-alpha by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methyglyoxal and glucose-derived advanced glycation endproducts
9. Effects of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages
10. Inhibitory effect of albumin-derived advanced glycation products on PMA-induced superoxide anion production by rat macrophages
11. Nitric oxide synthases in mammals
12. Nitric oxide: Pathophysiological mechanisms
13. Enhanced binding of advanced glycation end products (AGEs) by the ApoE4 isoform links the mechanism of plague deposition in Alzheimer's disease
14. Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine
15. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons
16. Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells
17. Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins
18. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells
19. Activation of the receptor for advanced glycation end products triggers a p21 (ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress
20. Advanced glycation end products stimulate mitogen activated protein kinase and proliferation in rabbit vascular smooth muscle cells
21. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogues with a rank order of potency characteristic of activated macrophages
22. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plagues
23. Widespread perxynitrite-mediated damage in Alzheimer's disease
24. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-non-responsive murine macrophages
25. Tyrosine kinase inhibitors and antioxidants modulate NF-κB and NOS-II induction in retinal epithelial cells
26. Promotor of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide
27. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors